Covid-19: 71% children show antibodies in sero survey, says PGIMER

According to a sero survey conducted by PGIMER, 71% of the 2,700 children in the samples developed antibodies. COVID-19. The samples were collected from Chandigarh, rural, urban areas and slum dwellers.

“We are at the beginning of the third wave of the COVID-19 pandemic. A serosurvey conducted by PGIMER, Chandigarh among 2700 children shows that 71 per cent of them developed antibodies. will not be disproportionately affected. PGIMER Director Dr Jagat Ram said while talking to the news agency ANI.

The director said, “About 69 per cent to 73 per cent of children have developed antibodies. On an average 71 per cent of samples have developed antibodies. We know that there is no vaccine available for children, so antibodies have developed to COVID-19.” Cause infection. So I don’t think the third wave will affect children.”

He said that surveys from Maharashtra and Delhi show that around 50-75 per cent children have developed antibodies. Jagat Ram said, “So various surveys show that the third wave will not be felt by the children.”

Stating that the peak may be delayed, he said people should follow COVID-appropriate behavior and vaccinate the eligible population.

He also noted that breakthrough infection is found within six to 10 percent of patients, adding that even if there is a breakthrough infection, the severity is very low.

Meanwhile, India witnessed a one-day increase of 27,254 new COVID-19 cases, taking the number of infections in the country to 3,32,64,175, while the number of active cases, according to data from the Union Health Ministry decreased to 3,74,269. Monday.

The death toll due to the disease has risen to 4,42,874, with 219 daily deaths being recorded, data updated at 8 am.

The ministry said the number of active cases has come down to 3,74,269, comprising 1.13 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 97.54 per cent.

A decrease of 10,652 cases has been recorded in the active COVID-19 caseload in the 24-hour period.

subscribe to mint newspaper

* Enter a valid email

* Thank you for subscribing to our newsletter!

Don’t miss a story! Stay connected and informed with Mint.
download
Our App Now!!

.

Leave a Reply